Skip to main content

RAMSAY SANTE : disposal of German facilities

Bergman Clinics takes next step in growth strategy with intended acquisition of six clinics in GermanyEntering German market strengthens Bergman’s position in Northwestern EuropeNAARDEN, Netherlands, September 16, 2020 – Bergman Clinics takes a next step in the expansion of its international position in the field of plannable medical care. The company now enters the German market, with the intended acquisition of six clinics in Germany from care group Capio, part of Ramsay Santé Group. This step follows an earlier acquisition in Scandinavia and strengthens Bergman’s position in Northwestern Europe. The German clinics are specialized in vein and eye care; two of the six are regional general hospitals. By expanding in Northwestern Europe, Bergman Clinics aims to create an international platform for highly specialized plannable medical care.The intended acquisition of the Capio clinics provides Bergman Clinics an entry into the largest European care market. Germany boasts a long history of plannable medical care through specialized clinics.
However, the market is fragmented, which offers consolidation opportunities and economies of scale. This intended acquisition represents an important step in Bergman Clinic’s growth strategy. By adding two regional general hospitals for general medical care, with a focus on orthopedic treatments, Bergman secures the needed licenses to further expand in Germany and to add focus clinics.
Bergman Clinics will also in Germany focus on high quality, patient focused treatments for a competitive price. Additionally, the increasing scale enables Bergman Clinics to achieve synergies. The German care activities will also contribute to benchmarking results between various clinics, which enables Bergman Clinics to continuously improve its care performance. Furthermore, the German clinics will be a platform for innovations in digital care.Around 200,000 patients are treated annually in the six clinics, of which around 180,000 represent outpatient treatments for plannable interventions in the areas of vein and eye surgery. Twenty thousand patients receive regional inpatient clinical care. The six clinics employ around 900 care professionals, of which 150 medical doctors and with a capacity of 540 beds. Most clinics are located in central Germany, one is located in Southern Bavaria. Bergman has the firm ambition to grow the clinics where possible, using the knowledge, experience and methods that Bergman Clinics also applies in its other locations, as well as through M&A. The main focus areas are movement, eye care, veins and appearance.Hans van der Heijden, CEO of Bergman Clinics, is thrilled with the acquisition. “We have been working on this project for a year. The process has been delayed due to Covid-19, but it’s very positive that we can now take this step. Achieving a leading position in Northwest European in our market, requires having a presence in Germany. We now have access to a potential that offers tremendous opportunities. Our employees in the Netherlands and Scandinavia can benefit from the knowledge and professionalism in Germany and at the same time we can insert our methodologies into the German clinics. Clients and patients will profit from this: they are being provided with more possibilities to get treatment from highly specialized focus clinics. Simultaneously, this joining of forces provides more room to invest in
technological innovations, digitization and training”.

Pascal Roché, CEO of Ramsay Santé Group, explains: “The Ramsay Santé group strategy aims to strengthen our presence in areas where we have the capacity to become a leader in the healthcare industry. We came to the conclusion that it would be very complex to be the case in Germany. We therefore accepted the offer of the Bergman Clinics group, whose expertise and development projects will be positive for the patients and the teams.”Completion of the acquisition is expected in the course of the fourth quarter of 2020.///Note to editorFor more information, please reach out to:Bergman ClinicsChristiaan Boer (Commercial Director & Corporate Communications | Bergman Clinics) E: C.Boer@bergmanclinics.com
T: +31 (0)6 51402152
About Bergman ClinicsFor nearly 30 years, Bergman Clinics has been one of the leading chains of independent clinics with 100 focus clinics throughout the Netherlands, Sweden, Denmark and Norway. The focus clinics offer high- quality, plannable medical care, with patients and the condition at the core. Bergman Clinics is a specialist for common treatments in the field of Movement, Eyes, Woman, Appearance, Heart, Stomach & Intestine and Skin & Vessels. Bergman Clinics has agreements with all health insurers and the vast majority of treatments are reimbursed from the basic package. Bergman Clinics treats more than 250,000 patients every year in the Netherlands and Scandinavia. More than 2,000 employees and more than 200 specialists work at Bergman Clinics.About Ramsay Santé GroupAfter the acquisition of Capio AB Group in 2018, Ramsay Santé has become one of the leaders of the private hospitalization and primary care in Europe with 36,000 employees and 8,600 practitioners serving 7 million patients in our 350 facilities in six countries: France, Sweden, Norway, Denmark, Germany, Italy. Ramsay Santé offers almost all medical and surgical specialties in three business areas: general hospitals (medicine – surgery – obstetric), follow-up care and rehabilitation clinics, mental health.AttachmentRAMSAY SANTE – disposal of German facilities

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.